Massive settlement in cancer-causing pesticide lawsuit! Bayer to pay $7.25 billion

Massive settlement in cancer-causing pesticide lawsuit! Bayer to pay $7.25 billion

21.11.2026 09:51

A judge in the U.S. state of Missouri approved a $7.25 billion settlement in lawsuits alleging that German company Bayer's weedkiller Roundup causes cancer. People who developed non-Hodgkin lymphoma after using Roundup or who will develop it in the future will benefit from this settlement. Per-person payments will range from $10,000 to $165,000.

Bayer's multibillion-dollar settlement proposed to end its Roundup lawsuits in the US has received court approval in Missouri. The company, however, does not admit the claims that the product causes cancer.

JUDGE: FAIR, REASONABLE AND ADEQUATE

According to BBC News, Judge Timothy Boyer said the settlement was "fair, reasonable and adequate." Bayer had proposed this payment to definitively end the legal battle in the US.

PAYMENTS OF UP TO $165,000 TO PATIENTS

The nationwide settlement will benefit people who used Roundup and developed non-Hodgkin lymphoma, as well as those who may develop the disease in the future. Per-person payments will range from $10,000 to $165,000 depending on how often the product was used, when the diagnosis was made, and the severity of the disease.

PAYMENTS TO BE SPREAD OVER 21 YEARS

Bayer will pay into a fund each year for up to 21 years, and the total amount will reach $7.25 billion. The amount the company has paid to date for Roundup lawsuits is about $10 billion.

LAWYERS' "INSUFFICIENT" OBJECTION

Some lawyers objected, arguing that the settlement amount was insufficient. Judge Boyer stated that he did not want to delay payments to patient victims.

BAYER REJECTS CANCER CLAIM

Bayer does not accept that Roundup causes cancer. In June, the US Supreme Court ruled 7-2 in Bayer's favor. The court ruled that because federal regulations do not require a cancer warning label, the company cannot be sued in state courts.

GLYPHOSATE DEBATE CONTINUES

Roundup was developed by Monsanto in the 1970s. The product's active ingredient, glyphosate, was classified in 2015 by the International Agency for Research on Cancer, part of the World Health Organization (WHO), as "probably carcinogenic to humans." However, some regulatory agencies, including Bayer and the US Environmental Protection Agency, oppose this assessment.

In order to provide you with a better service, we position cookies on our site. Your personal data is collected and processed within the scope of KVKK and GDPR. For detailed information, you can review our Data Policy / Disclosure Text. By using our site, you agree to our use of cookies.', '